Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Guo Wang, Xiaoyan Lin, Han Han, Hongxu Zhang, Xiaoli Li, Mei Feng & Chunming Jiang. (2022) lncRNA H19 promotes glioblastoma multiforme development by activating autophagy by sponging miR-491-5p. Bioengineered 13:5, pages 11440-11455.
Read now
Read now
Chao Yang, Jiang Shi, Jie Wang, Dexun Hao, Jinlu An & Junguang Jiang. (2021) Circ_0006988 promotes the proliferation, metastasis and angiogenesis of non-small cell lung cancer cells by modulating miR-491-5p/MAP3K3 axis. Cell Cycle 20:13, pages 1334-1346.
Read now
Read now
Articles from other publishers (11)
Majid Ghasemian, Mojtaba Zehtabi, Mahrokh Abouali Gale Dari, Fatemeh Khojasteh Pour, Ghasem Azizi Tabesh, Farideh Moramezi, Razieh Mohammad Jafari, Mojgan Barati, Shahab Uddin & Maryam Farzaneh. (2024) The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. BMC Cancer 24:1.
Crossref
Crossref
Xinyan Qiu & Jinlan Chen. (2023) LSINCT5: A Novel lncRNA in Cancers. Current Medicinal Chemistry 30:39, pages 4409-4420.
Crossref
Crossref
Chiara Zichittella, Marco Loria, Adriana Celesia, Diana Di Liberto, Chiara Corrado, Riccardo Alessandro, Sonia Emanuele & Alice Conigliaro. (2023) Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells. Frontiers in Pharmacology 14.
Crossref
Crossref
Lingxiao Wang, Chao Liang, Xiao Lin, Changying Liu & Jun Li. (2021) microRNA‐491‐5p regulates osteogenic differentiation of bone marrow stem cells in type 2 diabetes. Oral Diseases 29:1, pages 308-321.
Crossref
Crossref
Mehrdad Hashemi, Marzieh Sadat Moosavi, Hedyeh Maghareh Abed, Maryam Dehghani, Masoumeh Aalipour, Elaheh Ali Heydari, Mitra Behroozaghdam, Maliheh Entezari, Shokooh Salimimoghadam, Emine Selda Gunduz, Afshin Taheriazam, Sepideh Mirzaei & Saeed Samarghandian. (2022) Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacological Research 184, pages 106418.
Crossref
Crossref
Farzad Sadri, Seyede Fatemeh HosseiniAtena AghayeiMohammad Fereidouni & Zohreh Rezaei. (2022) The Tumor Suppressor Roles and Mechanisms of MiR-491 in Human Cancers. DNA and Cell Biology 41:9, pages 810-823.
Crossref
Crossref
Shuang Wang, Caixia Wang, Ouxuan Liu, Yuexin Hu, Xiao Li & Bei Lin. (2022) miRNA-651-3p regulates EMT in ovarian cancer cells by targeting ZNF703 and via the MEK/ERK pathway. Biochemical and Biophysical Research Communications 619, pages 76-83.
Crossref
Crossref
Deepshikha Singh, Yehuda G. Assaraf & Rajesh N. Gacche. (2022) Long non-coding RNA mediated drug resistance in breast cancer. Drug Resistance Updates 63, pages 100851.
Crossref
Crossref
Yingwei Wu, Bo Zhao, Xianghua Chen, Xueli Geng & Zhihua Zhang. (2021) Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway. International Journal of Laboratory Hematology 44:2, pages 320-332.
Crossref
Crossref
Qingshi Chen, Dandan Guo, Guofu Lin, Mengxue Chen, Jiefeng Huang & Qichang Lin. (2022) LncRNA XR_595552 inhibition alleviates intermittent hypoxia-induced cardiomyocyte damage via activating the PI3K/AKT pathway. Sleep and Breathing.
Crossref
Crossref
Wei-Chieh Huang, Hsiang-Cheng Chi, Shiao-Lin Tung, Po-Ming Chen, Ya-Chi Shih, Yi-Ching Huang & Pei-Yi Chu. (2021) Identification of the Novel Tumor Suppressor Role of FOCAD/miR-491-5p to Inhibit Cancer Stemness, Drug Resistance and Metastasis via Regulating RABIF/MMP Signaling in Triple Negative Breast Cancer. Cells 10:10, pages 2524.
Crossref
Crossref